COMMUNIQUÉS West-GlobeNewswire

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic
17/12/2025
COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne Louise Eberhard as new Chair of the Board of Directors, and in accordance with the [...]
CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system
17/12/2025
16 December 2025 CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical [...]
SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS
17/12/2025
SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS A major partnership to accelerate Safe's development in the Spanish market Fleurieux-sur-l’Arbresle – France – December 17, 2025 – 8am - Safe [...]
SAFE ANNONCE LA SIGNATURE D'UN CONTRAT DE DISTRIBUTION STRATEGIQUE EN ESPAGNE AVEC VORTROM BIOLOGICS
17/12/2025
SAFE ANNONCE LA SIGNATURE D'UN CONTRAT DE DISTRIBUTION STRATEGIQUE EN ESPAGNE AVEC VORTROM BIOLOGICS Un partenariat majeur pour accélérer le développement de Safe sur le marché espagnol Fleurieux-sur-l’Arbresle – France [...]
Press release: Availability of the Q4 2025 Aide memoire
17/12/2025
Availability of the Q4 2025 Aide memoire Paris, France – December 17, 2025 . Sanofi announced today that its Q4 2025 Aide memoire is available on the "Investors" page of the company's website: Fourth quarter & full [...]
Communiqué de presse : Mise en ligne du document «Q4 2025 Aide mémoire »
17/12/2025
Mise en ligne du document «Q4 2025 Aide mémoire » Paris, France, le 17 décembre 2025 . Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un document intitulé « Q4 2025 Aide [...]
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
17/12/2025
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands First Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7: [...]
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays-Bas
17/12/2025
Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays-Bas Premières implantations Genio réalisées avec succès dans les hôpitaux OLVG West et Zuyderland Mont-Saint-Guibert, Belgique – 17 [...]
Press Release: Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema
17/12/2025
Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi’s commitment to developing treatments for rare diseases [...]
Communiqué de presse : L’efdoralprine alfa de Sanofi obtient la désignation de médicament orphelin dans l’UE pour l’emphysème lié au déficit en alpha-1-antitrypsine
17/12/2025
L’efdoralprine alfa de Sanofi obtient la désignation de médicament orphelin dans l’UE pour l’emphysème lié au déficit en alpha-1-antitrypsine Une désignation de médicament orphelin supplémentaire renforce l’engagement [...]
Vireo Growth Inc. Enters into Definitive Agreement to Acquire Certain Assets of PharmaCann Inc.
17/12/2025
Acquired assets further optimize Vireo’s operating footprint in Colorado with addition of 17 dispensaries Transaction expands Vireo’s leadership position in the Colorado retail market with 41 total dispensaries Parties [...]
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
17/12/2025
BRISBANE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform targeting neuroinflammation across life-changing [...]
HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors
17/12/2025
— First-in-human trial of candidate from the next-generation ATTC platform — — Simultaneous China and global clinical development strategy to expedite development process — HONG KONG and SHANGHAI and FLORHAM PARK, N.J [...]
Medline Announces Pricing of Upsized Initial Public Offering
17/12/2025
NORTHFIELD, Ill., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) announced today the pricing of its upsized initial public offering of 216,034,482 shares of its Class A common stock, at a public offering [...]
Galecto, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16/12/2025
BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (the “Company” or “Galecto”) (Nasdaq: GLTO) today announced that the Company’s Board of Directors approved the grant of non-qualified stock options to purchase 312 [...]
Solid Biosciences Announces Duchenne Muscular Dystrophy Added to National Recommended Uniform Screening Panel by the U.S. Department of Health and Human Services
16/12/2025
CHARLESTOWN, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Health Care Advocates Slam Ford Government for Privatizing Surgeries While Pushing Public Hospitals into Deficit
16/12/2025
“A gross misuse of public funds” the Coalition warns as mass protests are planned TORONTO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Ontario’s public hospitals have been pushed into deficit and ordered to find cuts while the [...]
MAIA Biotechnology Announces $1.51 Million Private Placement
16/12/2025
CHICAGO, IL, Dec. 16, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today [...]
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
16/12/2025
HOUSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]

Pages